Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sexual Health Access at Retail Pharmacies (SHARP)
NCT07361926Not yet recruiting
- Sponsor
- University of Washington
- Start
- May 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of doxycycline in sexually transmitted infections (STI) (3 arms), sponsored by University of Washington. Primary endpoints: HIV PrEP initiation at 12 months, HIV PrEP persistence at 12 months and 1 more. Planned start May 2026; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
sexually transmitted infections (STI)
Beyond the preview
Go deeper on NCT07361926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07361926.